The Cancer Letter

Inside information on cancer research and drug development

In Brief

Kristin Ferguson named senior director of ACCC

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
DOWNLOAD PDFTABLE OF CONTENTS

Kristin Ferguson was named senior director of cancer care delivery and health policy at the Association of Community Cancer Centers.

Ferguson will lead the organization’s initiatives to improve cancer care delivery across rural, urban, and under-resourced settings, and will also provide support and resources to members of the oncology workforce, working to reshape reimbursement to better meet the needs of patients and providers.

Ferguson most recently served as clinical operations manager for the Lombardi Comprehensive Cancer Center at Medstar Georgetown University Hospital. There, Ferguson oversaw the daily operations of the clinic, ensured services met hospital and ONS standards, and monitored patient data collection, quality of care, and trends in clinical growth.

Ferguson has served as a voice for nursing and oncology in many policy-making forums, including the ONS Millennial Advisory Panel, the Oncology Nursing Society Congress Planning Team, AACN/ GNSA Policy Committee, Cancer Moonshot Summit and the Biden Cancer Summit town Hall. She has also advised and participated on research teams and is a member of an NINR Funded Research Team at Georgetown University on a grant to research symptom clusters in oncology patients.

Table of Contents

YOU MAY BE INTERESTED IN

Obituary

Felix Feng, GU cancer researcher who made fundamental discoveries in genomics, dies at 48

The University of California, San Francisco and global oncology communities mourn the death of Felix Y. Feng, MD, a radiation oncologist and a leading figure in genitourinary cancer research. A professor of radiation oncology, urology and medicine, and vice chair of translational research at the UCSF Helen Diller Family Comprehensive Cancer Center, Feng died from cancer on Dec.10, 2024. He was 48.
By Melinda Krigel
Obituary

Feng’s team advanced the understanding of biomarkers in prostate cancer

The late Felix Feng, MD (center) with researchers Jonathan Chou, MD, PhD (left) and Lisa Chesner, PhD (right), in 2019.Photo by Noah BergerFelix Y. Feng, a genitourinary cancer research leader, died on Dec. 10, 2024. He was 48.This article is republished with permission by NRG Oncology.Dr. Feng was the former NRG Oncology Genitourinary Cancer Committee chair and an RTOG Foundation member. After years of dedicated and enthusiastic commitment to the NRG and previously the RTOG Genitourinary Cancer Committee, chairing or co-chairing 13 research protocols for NRG and RTOG, Dr. Feng was appointed committee chair in March 2018, following in the footsteps of Dr. Howard Sandler, his mentor. Dr. Feng was also a member of the RTOG Foundation Board of Directors.
By NRG Staff
Table of Contents

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account